Business
HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference ...
About this update from Hls Therapeutics, Inc.
[{"type":"text","content":"\n \n \n \n HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference\n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n April 21, 2023\n \n \n /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS), a pharmaceutical company focusing on central nervous system (\"CNS\") and cardiovascular markets, announces that\n \n Tim Hendrickson\n \n , Chief Financial Officer, will present at the Bloom Burton & Co. Healthcare Investor Conference, which takes place\n \n Tuesday April 25 - Wednesday April 26\n \n , 2023 at the Metro Toronto Convention Centre, North Building, in downtown\n \n Toronto\n \n .\n \n \n HLS will present on\n \n April 25, 2023\n \n , at\n \n 11:30 a.m. Eastern Time\n \n . The Company's presentation will be webcast at:\n \n https://wsw.com/webcast/bloomburton8/hls.to/3108072\n \n . Mr. Hendrickson will also host one-on-one meetings with investors at the conference. To request a one-on-one meeting, please contact your Bloom Burton representative or place a request through the conference portal.\n \n \n \n ABOUT HLS THERAPEUTICS INC.\n \n \n \n Formed in 2015, HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS's focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages. For more information visit:\n \n \n www.hlstherapeutics.com\n \n \n \n \n \n ABOUT THE CONFERENCE\n \n \n \n The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadi...